KFL portfolio loss widened to NZ$19.5m but H2 reversed most of the H1 drawdown

What changed

KFL, a listed investment company, posted a full-year loss of NZ$19.5m versus NZ$17.3m, a 12.5% deterioration in NPAT and PBT (the two moved in lockstep, with tax of only NZ$0.023m immaterial to the result). The headline "revenue" line — effectively portfolio return including fair-value movements — was a NZ$14.7m loss, worse than the NZ$10.7m loss prior. Total assets and shareholders' equity both fell 8.7%, to NZ$462.2m and NZ$461.6m respectively, and cash on hand slipped from NZ$8.0m to NZ$6.4m. The liability stack is nominal (NZ$0.6m), so equity tracks assets almost 1:1. The final dividend was cut to 2.82 cents per share from 3.16 cents, a 10.8% reduction. Operating cash inflow surged to NZ$22.7m from NZ$3.2m, reflecting portfolio turnover rather than trading performance.

What matters

• H2 reversed most of the H1 drawdown. HY23 NPAT was a NZ$48.4m loss; the full year closed at a NZ$19.5m loss, implying a NZ$28.9m H2 profit. The trajectory is the more important read than the headline, because it says the portfolio recovered materially from the interim mark.
• NAV erosion, not operational decline. For a listed investment company the equity base is the product. An 8.7% fall in total equity to NZ$461.6m is the substantive issue — bigger in dollars (NZ$43.8m) than the reported loss because of dividend distributions on top of the investment loss.
• Dividend realignment. The final dividend was pared 10.8%, consistent with KFL's distribution policy scaling to NAV. Payout ratios against a loss-making NPAT (–47% current, –58% prior) are mechanically uninformative; the dividend cut is better read as a NAV-linked reset than as a cash-coverage signal.

Expectations

No forward guidance, NAV target, or quantitative objective was disclosed. Against the HY23 shape, the result substantially out-performed what a simple doubling of the interim loss would have implied — H1 NPAT alone was –NZ$48.4m, so the full-year –NZ$19.5m requires a NZ$28.9m positive swing in the second six months. The release does not disaggregate how much of that came from realised gains versus unrealised mark-to-market recovery, and it does not support any particular view on whether the H2 pace can persist into FY24.

Quality of result

For a LIC, the "earnings" number is dominated by unrealised fair-value movements on investments at fair value through profit or loss — the auditor's single key audit matter. That makes the NZ$19.5m loss almost entirely mark-to-market rather than operational, and neither durable nor recurring in any operating sense. The NZ$22.7m operating cash inflow (vs NZ$3.2m) is a portfolio-turnover artefact and should not be read as cash "earnings"; it reflects net realisations from buying and selling securities, not income generation. Liabilities are negligible, there are no borrowings, and the balance sheet remains essentially unlevered equity — so the result is high quality in the sense of being cleanly reported, but low in the sense that year-on-year comparability is driven by market direction rather than underlying execution.

Unresolved

• How much of the H2 NZ$28.9m positive swing was realised versus unrealised, and what portfolio mix or concentration drove it?
• What were gross subscriptions, redemptions, and dividend reinvestment contributions to the NZ$43.8m equity decline, versus the investment loss?
• Is the NAV-per-share and management-expense-ratio trajectory improving, deteriorating, or flat? The extraction does not expose per-share NAV.
• Why did cash balances fall to NZ$6.4m despite NZ$22.7m of operating inflow — presumably dividends and buybacks, but the financing outflows are not itemised here.

This briefing cannot assess portfolio composition, benchmark-relative performance, or per-share NAV movement, as none were present in the extracted release.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.